APA (7th ed.) Citation

He, G., Li, Q., Jing, X., Li, J., Gao, J., & Guo, X. (2024). Persistent response to combination therapy of pemigatinib and chemotherapy in a child of combined hepatocellular-cholangiocarcinoma with FGFR2 fusion. Molecular Cancer, 23(1), 1. https://doi.org/10.1186/s12943-024-02190-w

Chicago Style (17th ed.) Citation

He, Guo-qian, Qing Li, Xiao-yu Jing, Jian Li, Ju Gao, and Xia Guo. "Persistent Response to Combination Therapy of Pemigatinib and Chemotherapy in a Child of Combined Hepatocellular-cholangiocarcinoma with FGFR2 Fusion." Molecular Cancer 23, no. 1 (2024): 1. https://doi.org/10.1186/s12943-024-02190-w.

MLA (9th ed.) Citation

He, Guo-qian, et al. "Persistent Response to Combination Therapy of Pemigatinib and Chemotherapy in a Child of Combined Hepatocellular-cholangiocarcinoma with FGFR2 Fusion." Molecular Cancer, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12943-024-02190-w.